Bifogade filer
Year-end Report 2024
Kurs
+14,83%
Likviditet
9,51 MSEK
Prenumeration
Kalender
| Est. tid* | ||
| 2026-02-12 | 08:00 | Bokslutskommuniké 2025 |
| 2025-10-23 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-07-17 | 08:00 | Kvartalsrapport 2025-Q2 |
| 2025-05-09 | N/A | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2025-04-24 | 08:00 | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-10-24 | - | Kvartalsrapport 2024-Q3 |
| 2024-07-18 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-10 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2024-05-08 | - | Årsstämma |
| 2024-04-25 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-16 | - | Bokslutskommuniké 2023 |
| 2023-12-29 | - | Extra Bolagsstämma 2023 |
| 2023-10-26 | - | Kvartalsrapport 2023-Q3 |
| 2023-07-14 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-08 | - | X-dag ordinarie utdelning STIL 1.80 SEK |
| 2023-05-05 | - | Årsstämma |
| 2023-04-27 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-10-27 | - | Kvartalsrapport 2022-Q3 |
| 2022-07-15 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-06 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2022-05-05 | - | Årsstämma |
| 2022-05-01 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-10-27 | - | Kvartalsrapport 2021-Q3 |
| 2021-07-16 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-05 | - | X-dag ordinarie utdelning STIL 1.70 SEK |
| 2021-05-04 | - | Årsstämma |
| 2021-04-28 | - | Kvartalsrapport 2021-Q1 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-10-29 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-20 | - | Kvartalsrapport 2020-Q2 |
| 2020-05-28 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2020-05-27 | - | Årsstämma |
| 2020-04-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-20 | - | Bokslutskommuniké 2019 |
| 2019-10-31 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-03 | - | X-dag ordinarie utdelning STIL 1.45 SEK |
| 2019-05-02 | - | Årsstämma |
| 2019-05-02 | - | Kvartalsrapport 2019-Q1 |
| 2019-02-25 | - | Bokslutskommuniké 2018 |
| 2018-11-22 | - | Kvartalsrapport 2018-Q3 |
| 2018-08-23 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-17 | - | Kvartalsrapport 2018-Q1 |
| 2018-04-23 | - | X-dag ordinarie utdelning STIL 1.20 SEK |
| 2018-04-20 | - | Årsstämma |
| 2018-02-22 | - | Bokslutskommuniké 2017 |
| 2017-11-16 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-24 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-18 | - | Kvartalsrapport 2017-Q1 |
| 2017-04-27 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2017-04-26 | - | Årsstämma |
| 2017-02-16 | - | Bokslutskommuniké 2016 |
| 2016-11-17 | - | Kvartalsrapport 2016-Q3 |
| 2016-08-25 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-04-29 | - | X-dag ordinarie utdelning STIL 0.80 SEK |
| 2016-04-28 | - | Årsstämma |
| 2016-02-18 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-25 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-19 | - | Kvartalsrapport 2015-Q1 |
| 2015-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2015-04-15 | - | Årsstämma |
| 2015-02-18 | - | Bokslutskommuniké 2014 |
| 2014-11-19 | - | Kvartalsrapport 2014-Q3 |
| 2014-08-28 | - | Kvartalsrapport 2014-Q2 |
| 2014-07-30 | - | X-dag ordinarie utdelning STIL 1.00 SEK |
| 2014-05-14 | - | Kvartalsrapport 2014-Q1 |
| 2014-04-03 | - | Årsstämma |
| 2014-02-20 | - | Bokslutskommuniké 2013 |
| 2013-11-28 | - | Kvartalsrapport 2013-Q3 |
| 2013-08-29 | - | Kvartalsrapport 2013-Q2 |
| 2013-05-28 | - | Kvartalsrapport 2013-Q1 |
| 2013-04-26 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2013-04-25 | - | Årsstämma |
| 2013-02-20 | - | Bokslutskommuniké 2012 |
| 2012-11-20 | - | Kvartalsrapport 2012-Q3 |
| 2012-08-29 | - | Kvartalsrapport 2012-Q2 |
| 2012-05-16 | - | Kvartalsrapport 2012-Q1 |
| 2012-04-19 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2012-04-18 | - | Årsstämma |
| 2012-02-15 | - | Bokslutskommuniké 2011 |
| 2011-11-16 | - | Kvartalsrapport 2011-Q3 |
| 2011-08-24 | - | Kvartalsrapport 2011-Q2 |
| 2011-05-18 | - | Kvartalsrapport 2011-Q1 |
| 2011-04-14 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2011-04-13 | - | Årsstämma |
| 2011-02-16 | - | Bokslutskommuniké 2010 |
| 2010-11-24 | - | Kvartalsrapport 2010-Q3 |
| 2010-08-18 | - | Kvartalsrapport 2010-Q2 |
| 2010-04-16 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2010-04-15 | - | Kvartalsrapport 2010-Q1 |
| 2010-02-19 | - | Bokslutskommuniké 2009 |
| 2009-11-20 | - | Kvartalsrapport 2009-Q3 |
| 2009-08-27 | - | Kvartalsrapport 2009-Q2 |
| 2009-05-15 | - | X-dag ordinarie utdelning STIL 0.00 SEK |
| 2009-05-14 | - | Kvartalsrapport 2009-Q1 |
| 2009-04-15 | - | Årsstämma |
| 2008-06-24 | - | Split STIL 100:1 |
Beskrivning
| Land | Sverige |
|---|---|
| Lista | First North Stockholm |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Stille AB (publ) today presents the report for the fourth quarter and full year 2024.
Revenue amounted to MSEK 159.8 (77.3) driven by strong organic growth in surgical instruments, the successful acquisition of Fehling and solid growth in the US. Total growth amounted to 106.4 percent, of which 22.0 percent was organic growth.
“Earnings growth remains solid with an adjusted EBITDA margin of 28.4 percent.”, says Torbjörn Sköld and comments on the company’s strategic portfolio review where it was decided to phase out the table platform GS2 with a negative non-recurring effect of MSEK 24.1, “The decision is in line with our focus on high quality premium products for niche clinical segments and gives us the opportunity to focus on the recently launched imagiQ3 Legacy”.
The gross profit amounted to 57.1 percent (45.6) and EBITDA before non-recurring items amounted to MSEK 45.4 (17.7).
”2024 ended on a high note – our products are delivering value to our customers, which is creating favorable demand, strong growth and a healthy cash flow.”, concludes Stille’s CEO.
| MSEK | OCT-DEC 2024 | OCT-DEC 2023 | JAN-DEC 2024 | JAN-DEC 2023 |
| Net sales | 159.8 | 77.3 | 569.9 | 294.9 |
| Gross profit, % | 57.1 | 45.6 | 51.9 | 44.8 |
| EBITDA before non-recurring items | 45.4 | 17.7 | 145.2 | 62.6 |
| EBITDA before non-recurring items, % | 28.4 | 22.8 | 25.5 | 21.2 |
| EBITDA | 20.9 | 17.7 | 100.8 | 59.3 |
| EBITDA, % | 13.1 | 22.8 | 17.7 | 20.1 |
| EBIT before non-recurring items | 35.5 | 14.0 | 114.9 | 48.3 |
| EBIT before non-recurring items, % | 22.2 | 18.1 | 20.2 | 16.4 |
| EBIT | 11.1 | 14.0 | 70.5 | 45.0 |
| EBIT, % | 6.9 | 18.1 | 12.4 | 15.2 |
Torshälla, February 13th, 2025.
Contact Details
Torbjörn Sköld
CEO & President
+46 (0)70 316 63 91 | torbjorn.skold@stille.se
This information is information that Stille is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-02-13 08:00 CET.
About Us
Stille AB (publ) develops, manufactures and markets medical devices for surgeons across the world. Stille was founded in 1841 and is one of the world’s oldest medical device companies. Stille’s main business areas are surgical instruments and c-arm tables. Stille’s surgical instruments are mostly used during different kinds of open surgery. During minimal invasive procedures. the c-arm tables imagiQ2 and Medstone are key products. The company has a strong brand and products of a renowned high-quality. The share is listed on First North Growth Market under the acronym “STIL” with Eminova AB as Certified Adviser, Eminova Fondkommission AB, + 46 8 684 211 10, adviser@eminova.se. For more information, visit www.stille.se.
Attachments
Year-end Report 2024